Regeneron: Regeneron's Next Quarterly Earnings Report
Regeneron is gearing up to report its first-quarter results later this month, with market expectations pointing to a double-digit decline in earnings.
Read full article »
President & CEO
Leonard S. Schleifer
Regeneron is a New York-based biotechnology company that researches, develops, and commercializes novel therapeutics for the treatment of inflammatory and infectious diseases.
Read more